Article
Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
The Journal of steroid biochemistry and molecular biology - 1 Mar 2008
Skliris George P, Leygue Etienne, Watson Peter H, Murphy Leigh C
Abstract excerpt
Clinical management of breast cancer is increasingly guided by assessment of tumor phenotypic parameters. One of these is estrogen receptor (ER) status, currently defined by ERalpha expression. However with the discovery of a second ER, ERbeta and its variant isoforms, the definition of ER status is potentially more complex. In breast tumors there are two ERbeta expression cohorts. One where ERbeta is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
